Nita A. Limdi, Pharm.D., Ph.D, a professor in the Department of Neurology in the University of Alabama at Birmingham School of Medicine, has been awarded a 
Midcareer Investigator Award in patient-oriented research by the National Institutes of Health. The purpose of these awards, known as K24 grants, is to provide protected time to devote to patient-oriented research and to act as research mentors for clinical residents, clinical fellows, and/or junior clinical faculty.
Limdi, the interim director of the UAB Hugh Kaul Personalized Medicine Institute, is engaged in antithrombotic therapy pharmacogenomics research. Antithrombotic - or anticlotting - drugs commonly known as blood thinners, are widely used but can be challenging to prescribe.